ECDC symposium "Responding to two of the main STI threats of our time: syphilis and antimicrobial resistant Neisseria gonorrhoeae"
Presentation by: Otilia Mårdh
Presented at: IUSTI 2019, Tallinn
Presentation from the opening session of the 17th European AIDS Conference (EACS) 2019, Basel, Switzerland.
Presenter: Anastasia Pharris, European Centre for Disease Prevention and Control.
- There were 49,752 TB cases notified in 29 EU/EEA countries in 2019, with a notification rate of 9.6 per 100,000 population. The number and rate of TB cases have declined steadily between 2010-2019.
- Males had higher notification rates than females across all age groups over 14. The highest rate was in those aged 25-44.
- 34.5% of cases were in persons of foreign origin, up from 25.3% in 2010.
- Treatment success rates after 12 months of treatment declined from 76.2% in 2009 to 63.7% in 2018.
This document summarizes a presentation given by Anastasia Pharris of the European Centre for Disease Prevention and Control on infections among people who inject drugs. It finds that over 30,000 new HIV diagnoses in Europe in 2016 were due to injecting drug use, with most cases concentrated in Eastern Europe. While harm reduction efforts have made progress in some countries, people who inject drugs still face high burdens of HIV, hepatitis C, and other infections. The presentation calls for improved testing, treatment, and prevention programs targeting this group.
Summary slides on the epidemiological situation in the EU/EEA.
2018 surveillance data.
Report and ppt slides available from: http://bit.ly/HIVAIDSsurv18
The document summarizes the status of pre-exposure prophylaxis (PrEP) implementation in Europe based on data from 2018-2019. It finds that while formal PrEP rollout has been slow, especially in Eastern Europe and Central Asia, there is evidence of significant informal PrEP use across countries. As a result, an estimated 500,000 men who have sex with men (MSM) want or need PrEP but are unable to access it, representing a "PrEP gap" in Europe. Barriers to wider PrEP implementation include cost and lack of public funding in some countries.
1) Hepatitis E virus (HEV) infection has emerged as an important public health issue in Europe, with over 21,000 cases reported between 2005-2015 across EU/EEA countries.
2) Surveillance systems and case definitions for HEV vary between countries, but most (20/30) now have specific national surveillance for HEV in place.
3) The majority (98%) of HEV cases in Europe are now locally acquired rather than travel-associated, and over half of all cases are diagnosed in hospitals.
Presentation from the opening session of the 17th European AIDS Conference (EACS) 2019, Basel, Switzerland.
Presenter: Anastasia Pharris, European Centre for Disease Prevention and Control.
- There were 49,752 TB cases notified in 29 EU/EEA countries in 2019, with a notification rate of 9.6 per 100,000 population. The number and rate of TB cases have declined steadily between 2010-2019.
- Males had higher notification rates than females across all age groups over 14. The highest rate was in those aged 25-44.
- 34.5% of cases were in persons of foreign origin, up from 25.3% in 2010.
- Treatment success rates after 12 months of treatment declined from 76.2% in 2009 to 63.7% in 2018.
This document summarizes a presentation given by Anastasia Pharris of the European Centre for Disease Prevention and Control on infections among people who inject drugs. It finds that over 30,000 new HIV diagnoses in Europe in 2016 were due to injecting drug use, with most cases concentrated in Eastern Europe. While harm reduction efforts have made progress in some countries, people who inject drugs still face high burdens of HIV, hepatitis C, and other infections. The presentation calls for improved testing, treatment, and prevention programs targeting this group.
Summary slides on the epidemiological situation in the EU/EEA.
2018 surveillance data.
Report and ppt slides available from: http://bit.ly/HIVAIDSsurv18
The document summarizes the status of pre-exposure prophylaxis (PrEP) implementation in Europe based on data from 2018-2019. It finds that while formal PrEP rollout has been slow, especially in Eastern Europe and Central Asia, there is evidence of significant informal PrEP use across countries. As a result, an estimated 500,000 men who have sex with men (MSM) want or need PrEP but are unable to access it, representing a "PrEP gap" in Europe. Barriers to wider PrEP implementation include cost and lack of public funding in some countries.
1) Hepatitis E virus (HEV) infection has emerged as an important public health issue in Europe, with over 21,000 cases reported between 2005-2015 across EU/EEA countries.
2) Surveillance systems and case definitions for HEV vary between countries, but most (20/30) now have specific national surveillance for HEV in place.
3) The majority (98%) of HEV cases in Europe are now locally acquired rather than travel-associated, and over half of all cases are diagnosed in hospitals.
1) 58,994 TB cases were notified in 30 EU/EEA countries in 2016, with a notification rate of 11.4 per 100,000 population. The number and rate of TB cases have declined continuously between 2007-2016.
2) The highest notification rates in 2016 were among those aged 25-44, and males had higher rates than females in all groups over 14. Rates have declined annually by 2-4% in all age groups between 2007-2016.
3) 32.7% of cases in 2016 were in persons of foreign origin, an increase from 21% in 2007. The rate of cases in foreign-born persons was stable between 2007-2016.
Providing an overview on data, trends and summary of findings on the hepatitis B and C surveillance data from EU/EEA countries for the year 2017:
Find ECDC's Annual Epidemiological reports online: http://bit.ly/ECDCAER
This presentation summarises the main data from the ECDC Annual epidemiological reports 2017 on chlamydia, gonorrhoea, lymphogranuloma venereum, (congenital) syphilis
Data and trends from the ECDC Annual Epidemiological reports for 2016 on:
Chlamydia (http://bit.ly/AERch16)
Lymphogranuloma venereum (http://bit.ly/AERLGV16)
Gonorrhoea (http://bit.ly/AERsy16)
Syphilis (http://bit.ly/AERsy16)
Congenital syphilis (http://bit.ly/AERcs16)
See also: https://ecdc.europa.eu/en/annual-epidemiological-reports
ECDC poster at the 16th European AIDS Conference, 2017, Milan.
Authors: Lara Tavoschi, Joana Gomes-Dias, Anastasia Pharris, the EU/EEA HIV Surveillance Network
What is the current situation of HIV in Europe and Central Asia?
How can we more effectively prevent new infections?
Presentation by Anastasia Pharris,
European Centre for Disease Prevention and Control (ECDC)
at Glasgow HIV Drug Therapy Conference
28 October 2018
The document summarizes HIV/AIDS surveillance data in Europe for 2017. Some key findings are:
- 25,353 new HIV diagnoses were reported in 30 EU/EEA countries in 2017.
- Sex between men accounted for 38% of new diagnoses, while heterosexual transmission accounted for 33%.
- Nearly half (49%) of individuals were diagnosed late, with a CD4 count below 350 cells/mm3.
- Migrants accounted for 41% of new diagnoses, many originating from sub-Saharan Africa and Latin America.
Although HIV is preventable through effective public health measures, significant HIV transmission continues in Europe. In 2015, almost 30 000 people were diagnosed in European Union and European Economic Area Member States; a rate of 6.3 cases in every 100 000 people (when adjusted for reporting delay).
This report, prepared jointly with the WHO Regional Office for Europe, presents data on HIV and AIDS for the whole European Region, including the EU and EEA countries. Analyses are provided for the EU and EEA region.
The document discusses HIV infection among children and adolescents in the European Union and European Economic Area (EU/EEA). It provides statistics on new HIV diagnoses from 2006-2015, showing an increase among adolescents ages 15-19. The majority of infections in children under 15 were due to mother-to-child transmission, while most adolescents were infected through heterosexual sex or sex between men. While mother-to-child transmission rates are declining in EU/EEA-born children, transmission remains high in children born outside the EU/EEA to migrant mothers. The document calls for targeted HIV prevention strategies focusing on at-risk groups.
This document summarizes a presentation on estimating mortality due to viral hepatitis using attributable fractions. It discusses:
1) The WHO reference method which uses national mortality statistics and attributable fraction estimates from GBD to estimate hepatitis-related deaths.
2) A sentinel pilot study conducted in Bulgaria and Portugal to develop local estimates of the attributable fractions of cirrhosis and liver cancer caused by hepatitis B and C. The pilot found the attributable fractions varied between sites.
3) Outcomes from the pilot included improved local mortality estimates and lessons learned for expanding the methodology to other countries through clinical and public health partnerships. Limitations around representing overall populations and assigning morbidity to mortality were also noted.
This document analyzes EU surveillance data from 2009-2014 on shigellosis, a bacterial infection transmitted through contaminated food or water or directly from person to person through feces. The analysis found that domestically-acquired shigellosis cases increased over this period and accounted for over half of reported cases in 2014, with the proportion of cases among men doubling. Male-to-female ratios were highest among domestic cases, suggesting ongoing sexual transmission of certain Shigella strains like S. flexneri serotype 3a among men who have sex with men in Europe. The authors conclude countries should investigate domestic male cases and sexual transmission more and report such data to help monitor trends and facilitate public health interventions.
Based on ECDC surveillance report on Sexually transmitted infections in Europe 2013, these slides describes the epidemiological features and basic trends of the five STI under EU surveillance: chlamydia trachomatis infection, gonorrhoea, syphilis, congenital syphilis, and lymphogranuloma venereum. It covers the years 2004 to 2013.
In 2014, over 57 000 new cases of hepatitis B and C were reported. 22 442 cases of hepatitis B virus infection were reported in 30 EU/EEA Member States and 35 321 cases of hepatitis C were reported from 28 EU/EEA Member States.
This document summarizes measles and rubella surveillance trends in Europe from 2013-2016 based on data reported to the European Centre for Disease Prevention and Control. It finds that while measles cases decreased between 2008-2011, they have since increased, with over 3700 cases reported in EU/EEA countries in 2016. The majority of measles cases were either unvaccinated or had an inadequate vaccination status. Rubella cases have remained low and stable during this period, with 1307 total cases reported in EU/EEA countries in 2016.
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: ECDC's HIV expert Anastasia Pharris
a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
Presentation by ECDC HIV expert Anastasia Pharris on epidemiological challenges for the HIV response in Europe.
Presented at: 16th European AIDS Conference, 26 October 2017, Milan.
Although HIV is preventable through effective public health measures, significant HIV transmission continues in Europe. In 2014, almost 30 000 people were diagnosed in European Union and European Economic Area Member States. This slide set includes maps, graphs and tables from the 2014 HIV/AIDS surveillance report, published jointly by ECDC and WHO Europe.
Surveillance data from 2013 show high numbers of newly diagnosed hepatitis B and C cases notified across Europe. Chronic cases dominate across both diseases with a marked variation between countries: in 2013, 19 930 cases of hepatitis B virus infection were reported in 28 EU/EEA Member States, a crude rate of 4.4 per 100 000 population. 26 EU/ EEA Member States recorded 32 512 cases of hepatitis C resulting in a crude rate of 9.9 per 100 000 population.
Summary of surveillance data for hepatitis B and hepatitis C across the European Union and European Economic area for 2016.
See also:
ECDC's Annual Epidemiological Report hepatitis B: http://bit.ly/AER16HBV
ECDC's Annual Epidemiological Report hepatitis C: http://bit.ly/AER16HCV
There is a growing body of evidence indicating an increased burden of HIV among older adults. We describe the socio-demographic profile of adults aged 50 years and
over that are newly diagnosed with HIV in the European Union/European Economic Area (EU/EEA), to inform HIV testing and prevention efforts.
Poster at EACS 2015.
1) 58,994 TB cases were notified in 30 EU/EEA countries in 2016, with a notification rate of 11.4 per 100,000 population. The number and rate of TB cases have declined continuously between 2007-2016.
2) The highest notification rates in 2016 were among those aged 25-44, and males had higher rates than females in all groups over 14. Rates have declined annually by 2-4% in all age groups between 2007-2016.
3) 32.7% of cases in 2016 were in persons of foreign origin, an increase from 21% in 2007. The rate of cases in foreign-born persons was stable between 2007-2016.
Providing an overview on data, trends and summary of findings on the hepatitis B and C surveillance data from EU/EEA countries for the year 2017:
Find ECDC's Annual Epidemiological reports online: http://bit.ly/ECDCAER
This presentation summarises the main data from the ECDC Annual epidemiological reports 2017 on chlamydia, gonorrhoea, lymphogranuloma venereum, (congenital) syphilis
Data and trends from the ECDC Annual Epidemiological reports for 2016 on:
Chlamydia (http://bit.ly/AERch16)
Lymphogranuloma venereum (http://bit.ly/AERLGV16)
Gonorrhoea (http://bit.ly/AERsy16)
Syphilis (http://bit.ly/AERsy16)
Congenital syphilis (http://bit.ly/AERcs16)
See also: https://ecdc.europa.eu/en/annual-epidemiological-reports
ECDC poster at the 16th European AIDS Conference, 2017, Milan.
Authors: Lara Tavoschi, Joana Gomes-Dias, Anastasia Pharris, the EU/EEA HIV Surveillance Network
What is the current situation of HIV in Europe and Central Asia?
How can we more effectively prevent new infections?
Presentation by Anastasia Pharris,
European Centre for Disease Prevention and Control (ECDC)
at Glasgow HIV Drug Therapy Conference
28 October 2018
The document summarizes HIV/AIDS surveillance data in Europe for 2017. Some key findings are:
- 25,353 new HIV diagnoses were reported in 30 EU/EEA countries in 2017.
- Sex between men accounted for 38% of new diagnoses, while heterosexual transmission accounted for 33%.
- Nearly half (49%) of individuals were diagnosed late, with a CD4 count below 350 cells/mm3.
- Migrants accounted for 41% of new diagnoses, many originating from sub-Saharan Africa and Latin America.
Although HIV is preventable through effective public health measures, significant HIV transmission continues in Europe. In 2015, almost 30 000 people were diagnosed in European Union and European Economic Area Member States; a rate of 6.3 cases in every 100 000 people (when adjusted for reporting delay).
This report, prepared jointly with the WHO Regional Office for Europe, presents data on HIV and AIDS for the whole European Region, including the EU and EEA countries. Analyses are provided for the EU and EEA region.
The document discusses HIV infection among children and adolescents in the European Union and European Economic Area (EU/EEA). It provides statistics on new HIV diagnoses from 2006-2015, showing an increase among adolescents ages 15-19. The majority of infections in children under 15 were due to mother-to-child transmission, while most adolescents were infected through heterosexual sex or sex between men. While mother-to-child transmission rates are declining in EU/EEA-born children, transmission remains high in children born outside the EU/EEA to migrant mothers. The document calls for targeted HIV prevention strategies focusing on at-risk groups.
This document summarizes a presentation on estimating mortality due to viral hepatitis using attributable fractions. It discusses:
1) The WHO reference method which uses national mortality statistics and attributable fraction estimates from GBD to estimate hepatitis-related deaths.
2) A sentinel pilot study conducted in Bulgaria and Portugal to develop local estimates of the attributable fractions of cirrhosis and liver cancer caused by hepatitis B and C. The pilot found the attributable fractions varied between sites.
3) Outcomes from the pilot included improved local mortality estimates and lessons learned for expanding the methodology to other countries through clinical and public health partnerships. Limitations around representing overall populations and assigning morbidity to mortality were also noted.
This document analyzes EU surveillance data from 2009-2014 on shigellosis, a bacterial infection transmitted through contaminated food or water or directly from person to person through feces. The analysis found that domestically-acquired shigellosis cases increased over this period and accounted for over half of reported cases in 2014, with the proportion of cases among men doubling. Male-to-female ratios were highest among domestic cases, suggesting ongoing sexual transmission of certain Shigella strains like S. flexneri serotype 3a among men who have sex with men in Europe. The authors conclude countries should investigate domestic male cases and sexual transmission more and report such data to help monitor trends and facilitate public health interventions.
Based on ECDC surveillance report on Sexually transmitted infections in Europe 2013, these slides describes the epidemiological features and basic trends of the five STI under EU surveillance: chlamydia trachomatis infection, gonorrhoea, syphilis, congenital syphilis, and lymphogranuloma venereum. It covers the years 2004 to 2013.
In 2014, over 57 000 new cases of hepatitis B and C were reported. 22 442 cases of hepatitis B virus infection were reported in 30 EU/EEA Member States and 35 321 cases of hepatitis C were reported from 28 EU/EEA Member States.
This document summarizes measles and rubella surveillance trends in Europe from 2013-2016 based on data reported to the European Centre for Disease Prevention and Control. It finds that while measles cases decreased between 2008-2011, they have since increased, with over 3700 cases reported in EU/EEA countries in 2016. The majority of measles cases were either unvaccinated or had an inadequate vaccination status. Rubella cases have remained low and stable during this period, with 1307 total cases reported in EU/EEA countries in 2016.
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: ECDC's HIV expert Anastasia Pharris
a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
Presentation by ECDC HIV expert Anastasia Pharris on epidemiological challenges for the HIV response in Europe.
Presented at: 16th European AIDS Conference, 26 October 2017, Milan.
Although HIV is preventable through effective public health measures, significant HIV transmission continues in Europe. In 2014, almost 30 000 people were diagnosed in European Union and European Economic Area Member States. This slide set includes maps, graphs and tables from the 2014 HIV/AIDS surveillance report, published jointly by ECDC and WHO Europe.
Surveillance data from 2013 show high numbers of newly diagnosed hepatitis B and C cases notified across Europe. Chronic cases dominate across both diseases with a marked variation between countries: in 2013, 19 930 cases of hepatitis B virus infection were reported in 28 EU/EEA Member States, a crude rate of 4.4 per 100 000 population. 26 EU/ EEA Member States recorded 32 512 cases of hepatitis C resulting in a crude rate of 9.9 per 100 000 population.
Summary of surveillance data for hepatitis B and hepatitis C across the European Union and European Economic area for 2016.
See also:
ECDC's Annual Epidemiological Report hepatitis B: http://bit.ly/AER16HBV
ECDC's Annual Epidemiological Report hepatitis C: http://bit.ly/AER16HCV
There is a growing body of evidence indicating an increased burden of HIV among older adults. We describe the socio-demographic profile of adults aged 50 years and
over that are newly diagnosed with HIV in the European Union/European Economic Area (EU/EEA), to inform HIV testing and prevention efforts.
Poster at EACS 2015.
Data and trends on hepatitis B and C for the countries of the European Union and European Economic Area.
2015 data.
See also ECDC's Annual Epidemiological Report: https://ecdc.europa.eu/en/annual-epidemiological-reports
Антиретровирусное лечение – перспективы Европейского клинического общества по...hivlifeinfo
Антиретровирусное лечение – перспективы Европейского клинического общества по СПИДу (EACS)/Antiretroviral Treatment.The European AIDS Clinical Society (EACS) Perspective.2017
Poster presentation at the AIDS 2018 conference in Amsterdam.
By: Marieke J. van der Werf and Csaba Ködmön, European Centre for Disease Prevention and Control, ECDC.
An overview on how European countries have been responding to the HIV epidemic since 2004 based on the commitments as outlined in the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia.
The document summarizes key points from a presentation on developing a Model of Care to address tuberculosis (TB) in London. It outlines three main aspects the model aims to improve: 1) detection and diagnosis of TB through raising awareness in high-risk communities and among healthcare workers, and piloting active/latent case finding; 2) coordinated commissioning of TB services; and 3) reducing variability in service provision across London. The model was developed through extensive stakeholder engagement to address increasing TB rates in London and risks of further fragmentation, unequal care, and drug-resistant TB without changes to the current system.
1st Hepatitis E virus expert meeting at ECDC, IntroductionCornelia Adlhoch
The expert group meeting discussed hepatitis E virus (HEV) epidemiology, surveillance, and risks in the EU/EEA. HEV is an under-surveilled cause of hepatitis worldwide with different genotypes infecting people. While most EU cases were previously travel-related, HEV genotype 3 is now endemic in Europe with an animal reservoir. Surveillance varies between countries with no EU-wide system. The group aims to inventory HEV in Europe by surveying countries on surveillance methods and collecting case numbers to describe epidemiology and populations at risk. This will identify needs for EU guidance on diagnosis, risk assessment, and prevention strategies to respond to HEV health threats.
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: Sophocles Chanos
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
The meaning of meningococcal carriage - Slideset by Professor Adam FinnWAidid
Professor Finn on the risks of meningococcal
disease. The slideset face the effects of vaccines, the speculation about meningococcal infection and respiratory viruses, so as the epidemiology & evolving vaccine
strategies in Europe and Africa.
Public injecting, harm reduction servicesJozsef Racz
This ERASMUS lecture is about a Hungarian public injection scene, about the local harm reduction services (run by Blue Point Drug Counselling and Outpatient Centre) and about connections of public injecting to other risks, including "police risks".
In 2012, 29,381 new HIV diagnoses were reported in the EU/EEA region, with a rate of 5.8 per 100,000 population. Men who have sex with men accounted for 40.4% of transmissions, while heterosexual contact was 33.8% and injecting drug use was 6.1%. Half of infections were diagnosed at an advanced stage. While HIV levels are low among injecting drug users in most countries, some have seen increases. Interventions must be tailored to local epidemics and focus on testing and treatment to both help individuals and reduce further transmission in vulnerable groups like men who have sex with men.
Improving the understanding of chlamydia epidemiology in Europe –scoping for the rationale of a European Union prevalence survey.
Across Europe, there is considerable variation in reported chlamydia cases by country - likely mirroring substantial heterogeneity in testing, diagnostics and surveillance rather than differences in prevalence.
A European-wide survey has been proposed as a means of improving understanding of the epidemiology of chlamydia in Europe.
This poster was presented at the 8th meeting of the European Society for Chlamydia Research, ESCR, 2016.
Chemsex - the 'ins and outs' of managing an outbreak: a local health protecti...UKFacultyPublicHealth
A local health protection team was notified in May 2014 of an STI outbreak among men who had sex with men involved in chemsex (sex under the influence of drugs) in London. The team coordinated the response, which included investigating transmission networks, heightened surveillance, targeted health promotion through dedicated clinics and outreach, and improving integration between sexual health and drug services. Challenges included obtaining accurate surveillance data while maintaining confidentiality and addressing ongoing risky behaviors like illicit drug use. Lessons showed a need for more tailored services and cross-sector collaboration to respond to changing behaviors.
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: Masoud Dara, WHO Regional Office for Europe
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
Teymur Noori, ECDC
22nd International AIDS Conference, Amsterdam 2018
2018 European African HIV/AIDS & Hepatitis C Community Summit. "Our Voices Matter for a lasting solution!!"
Developing Urban Health Indicators for Low Income Countries: A Case Studysteelss
These slides are from a quest lecture given at the Institute for Sustainable Futures at the University of Technology Sydney, Australia (2012).
It gives an overview of my PhD study which was centred on investigating the potential health implications of urbanisation in Vietnam, in addition to exploring NGO engagement with policy makers and government authorities in implementing public health policy.
Presentation made by Zsuzsanna Jakab, WHO Regional Director for Europe, at the meeting "Health in Action reforming the Greek National Health System to Improve Citizens’ Health", on 5 March 2014, Athens, Greece.
Similar to The public health response to increasing syphilis trends in Europe (20)
Respondent Driven Sampling (RDS) is a technique for sampling hard-to-reach populations. It works by having initial participants (seeds) recruit a small number of people from their social networks, who are then eligible to recruit others from their networks. This process continues in successive waves. RDS relies on assumptions about network structure and recruitment behaviors. Analysis adjusts for network size and recruitment patterns. The technique was used to sample migrants in Morocco to estimate HIV, syphilis, and tuberculosis prevalence and understand their demographics, risks, and access to services. Results provided insights to guide health programs for this population.
Poster presentation at the AIDS 2018 conference in Amsterdam.
By: Adam Bourne1, Beatrice Alba1, Alex Garner2, Gianfranco Spiteri3, Anastasia Pharris3, Teymur Noori3
1. Australian Research Centre in Sex, Health & Society, La Trobe University, Melbourne, Australia; 2. Hornet Gay Social Network, California, USA; 3. European Centre for Disease Prevention and Control, ECDC, Sweden
Presentation by Daniel Simões, HIV in Europe, Portugal , at AIDS 2018 conference during the joint ECDC and EACS satellite "Getting to 90: Addressing inequalities in the HIV continuum of care in Europe and Central Asia"
Presentation by Jens Lundgren, Rigshospitalet, University of Copenhagen - European AIDS Clinical Society, Denmark, at AIDS 2018 conference during the joint ECDC and EACS satellite "Getting to 90: Addressing inequalities in the HIV continuum of care in Europe and Central Asia"
Presentation by Chloe Orkin, Royal London Hospital - BHIVA, United Kingdom, at AIDS 2018 conference during the joint ECDC and EACS satellite "Getting to 90: Addressing inequalities in the HIV continuum of care in Europe and Central Asia"
Presentation by Teymur Noori, ECDC, at AIDS 2018 conference during teh joint ECDC and EACS satellite "Getting to 90: Addressing inequalities in the HIV continuum of care in Europe and Central Asia"
Presentation by: Erika Duffell, European Centre for Disease Prevention and Control, Stockholm, Sweden
Presentad at: International Liver Congress, April 2018
This document summarizes tuberculosis monitoring indicators for the WHO European Region in 2016. It analyzes 19 indicators across three areas of intervention: integrated patient-centered care and prevention, bold policies and supportive systems, and intensified research and innovation. For most indicators, only a small number of countries met the targets, suggesting more progress is still needed to tackle TB across the European Region.
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
The public health response to increasing syphilis trends in Europe
1. The public health response to increasing
syphilis trends in Europe
Otilia Mårdh, Gianfranco Spiteri, Aitana Morano-Vazquez, Andrew Amato
ECDC
IUSTI 2019, Tallinn
S18 - ECDC Symposium: Responding to two of the main STI threats of our time: syphilis and antimicrobial resistant
Neisseria gonorrhoeae
2. Background
• Since 2010, substantial increases in syphilis notifications
rates in EU, mainly MSM;
• Increasing trends and outbreaks also in other high-income
countries (e.g. US, Japan, Canada, Australia)
• September 2018 – request of Member States to ECDC
(update on epidemiology, options for response)
• July 2019 – ECDC technical report
2
3. Methods
Update on syphilis
epidemiology
Non-systematic literature
review *
2007-2018
PubMed, Embase, Scopus
Identify trends, describe recent
outbreaks,
identify drivers of syphilis
epidemic
Surveillance data analysis
2007-2017
ECDC TESSy
Member States survey
2019
Changes in surveillance,
recent data
3
*EU/EEA, EU candidate countries, high-income countries (Australia, Canada, Japan, New Zealand and the USA)
Options for response
Systematic literature review*
2007-2018
PubMed, Embase, Scopus,
Cochrane, Google-, hand-
searches
Member States survey
2019
Models of practice
Collect the evidence-base and
formulate options for response
Source: ECDC Syphilis and congenital syphilis in Europe - A review of epidemiological trends (2007–2018) and options for response. 2019
Objectives Outcomes
5. Syphilis EU/EEA, 2007-2017
5
0.0
2.0
4.0
6.0
8.0
10.0
12.0
14.0
2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Men
Total
Women
*not from Liechtenstein
Rates of syphilis infections per 100,000 population by year of
notification, EU/EEA countries
Note: includes reports from countries with comprehensive surveillance systems and consistent reporting over the period:
Bulgaria, Cyprus, the Czech Republic, Denmark, Estonia, Finland, Germany, Iceland, Ireland, Italy, Latvia, Lithuania,
Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden and the United Kingdom.
Source: ECDC Surveillance Atlas https://atlas.ecdc.europa.eu/public/index.aspx
• 260,505 syphilis cases, 30/31
Member States*
• EU/EEA rate from 4.6 in 2007 to
7.1 in 2017
6. • 260,505 syphilis cases, 30/31
Member States*
• EU/EEA rate from 4.6 in 2007 to
7.1 in 2017
• M:F 3 in 2007 to 8.5 in 2017
Syphilis EU/EEA, 2007-2017
6
0.0
2.0
4.0
6.0
8.0
10.0
12.0
14.0
2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Men
Total
Women
*not from Liechtenstein
Rates of syphilis infections per 100,000 population by year of
notification, EU/EEA countries
Note: includes reports from countries with comprehensive surveillance systems and consistent reporting over the period:
Bulgaria, Cyprus, the Czech Republic, Denmark, Estonia, Finland, Germany, Iceland, Ireland, Italy, Latvia, Lithuania,
Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden and the United Kingdom.
Source: ECDC Surveillance Atlas https://atlas.ecdc.europa.eu/public/index.aspx
7. 0
2000
4000
6000
8000
10000
12000
14000
16000
2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Numberofcases
MSM
Heterosexual men
Women
Syphilis EU/EEA, 2007-2017
7
Number of syphilis infections by route of transmission*
Note: includes reports from Cyprus, the Czech Republic, Denmark, France, Germany, Iceland, Ireland, Latvia, Lithuania, Malta, the
Netherlands, Norway, Romania, Slovenia, Sweden and the United Kingdom.
*Reported for 152,233 (58%) cases
Overall, 2007-2017
MSM 62% 94,015
Heterosexual men 23% 35,633
Women 15% 22,242
Source: ECDC Surveillance Atlas https://atlas.ecdc.europa.eu/public/index.aspx
8. Syphilis EU/EEA, 2014- 2017
2014 2015 2016 2017
Women 2.6% 2.1% 3.1% 1.8%
Heterosexual men 12% 12% 10% 10%
MSM 45% 44% 41% 39%
8
HIV co-infection
*includes 39,340 cases with known HIV status reported as MSM, heterosexual men
and heterosexual women between 2014-2017.
Source: ECDC Surveillance Atlas https://atlas.ecdc.europa.eu/public/index.aspx
Percentage HIV-positive syphilis cases*
0
1000
2000
3000
4000
5000
6000
2014 2015 2016 2017
Numberofcases
MSM HIV-
MSM HIV+
Number of syphilis infections by HIV-status among MSM
9. Syphilis EU/EEA, 2014-2017
9
0%
10%
20%
30%
40%
50%
60%
Women (n=3,986) Heterosexual men
(n=6,136)
MSM (n=24,278)
Percentage
Primary
Secondary
Early latent
Late latent
Latent (unknown duration)
Stage of syphilis infection at diagnosis
Note: includes reports from the Czech Republic, France, Hungary,
Iceland, Ireland, Latvia, Lithuania, Luxembourg, Malta, the
Netherlands, Norway, Portugal, Romania, Slovakia, Slovenia,
Sweden, the United Kingdom
• Most cases reported as early latent infection
• 49% of women as early latent infections
• Primary stage: 35% MSM, 31% MSW, 15%
WSM
Source: ECDC Surveillance Atlas https://atlas.ecdc.europa.eu/public/index.aspx
10. 10
Literature review on syphilis epidemiology
Studies reporting increasing trends and outbreaks by country and year of publication
Note: search conducted in PubMed, Embase, Scopus 2007-2018; studies
from the EU/EEA, EU candidate countries, high-income countries:
Australia, Canada, Japan, New Zealand and the USA. Five studies with
multi-country coverage not represented.
Trends Outbreaks
Australia 3 3
Canada 3 2
Switzerland 1
Czech Republic 1
Germany 2
Spain 7
Finland 1
France 2
Greece 1 2
Ireland 1
Japan 1
Netherlands 1 1
New Zeeland 3
Poland 1
Portugal 1
Romania 2
Serbia 1
UK 8 13
USA 20 7
Total 59 29
Source: ECDC Syphilis and congenital syphilis in Europe - A review of epidemiological trends (2007–2018) and options for response. 2019
• 19 countries, 14 European
11. 11
Literature review on syphilis epidemiology
Studies reporting increasing trends/outbreaks by risk group, country and year of publication
Note: search conducted in PubMed, Embase, Scopus 2007-2018; studies from the
EU/EEA, EU candidate countries, high-income countries: Australia, Canada, Japan,
New Zealand and the USA.
* Other includes: sex workers, military, blood donors, prisoners, PWID
Heterosexuals
HIV-positive
Migrants
MSM,bisexuals
Other*
Pregnantwomen
Albania 2
Belgium 1
Canada 2 1
France 1 1
Germany 2 2
Greece 1
Ireland 1
Italy 1 1 2
Poland 2 2
Romania 1
Serbia 1
Spain 3 2 2 1
Sweden 1
Switzerland 2 1
Netherlands 2
UK 1 3
USA 6 8 7 4 3
Total 6 21 5 17 13 8
Source: ECDC Syphilis and congenital syphilis in Europe - A review of epidemiological trends (2007–2018) and options for response. 2019
• 68 studies, 17 countries
12. Factors driving syphilis increases in EU/EEA and high income
countries, 2007-2018, literature review results
• high rates of condomless sex
• increased number of sex partners (HIV-
negative MSM)
• serosorting (HIV-positive MSM)
• impact of PrEP for HIV
• use of social networking sites or mobile
device application
12
Source: ECDC Syphilis and congenital syphilis in Europe - A review of epidemiological trends (2007–2018) and options for response. 2019
• condomless sex
• multiple sex partners
• substance use (drug or alcohol)
• young age
• history of incarceration
• sex work
• previous STI
• social vulnerabilities (e.g. poverty,
homelessness, ethnic minority, migrant or
refugee status)
MSM Heterosexual men and women
13. Katsushika Hokusai. The Great Wave off Kanagawa
Options for response
How can we turn the tide?
13
2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
14. 14
0
2
4
6
8
10
12
2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
No.ofstudies
Year of publication
Biomedical interventions
Interventions using social media
Education
Partner notification
Outreach venues testing
Screening
Source: ECDC Syphilis and congenital syphilis in Europe - A review of epidemiological trends (2007–2018) and options for response. 2019
Screening
Outreachvenuestesting
Partnernotification
Education
Socialmedia
Biomedical
Australia 5 3 1
France 1
Ireland 1
Netherlands 1
New Zeeland 1
UK 1 4 1
USA 8 1 6 11 4 1
Total 15 5 6 15 6 3
Systematic literature review on response interventions
Studies reporting single interventions with a documented impact among adult populations
Note: search conducted in PubMed, Embase,
Scopus, CDSR, Google, hand searches; studies from
the EU/EEA, EU candidate countries, high-income
countries: Australia, Canada, Japan, New Zealand
and the USA. Nine other studies reporting
multiple interventions for outbreak response
summarised in the report.
• 50 studies, 7 countries
15. Public health responses to increases in syphilis should aim to identify and treat
syphilis cases and prevent new infections.
Combining,
15
Case finding
Screening/testing
Partner notification and
management
Surveillance
Case management
Appropriate treatment
Risk reduction counseling
Education
General population
Populations at higher risk
Healthcare providers
Source: ECDC Syphilis and congenital syphilis in Europe - A review of epidemiological trends (2007–2018) and options for response. 2019
16. 1. Enhanced screening of populations at risk
Testing of other risk groups e.g. ethnic minorities, marginalised populations, sex workers, PWID - to be
informed by local epidemiology
16
Source: ECDC Syphilis and congenital syphilis in Europe - A review of epidemiological trends (2007–2018) and options for response. 2019
Population Intervention Outcome
HIV-positive MSM Include syphilis testing in routine HIV
clinical monitoring, 3- or 6-monthly, opt-
out vs risk based Increase detection of
early/asymptomatic syphilis
infections
HIV-negative MSM
• with high no. of sex partners
• PrEP users
• with prior syphilis diagnosis
Quarterly testing vs. bi-annual or
symptom based
STI clinics attendees Routine testing as per clinical guidelines Increase detection of syphilis
infections
Reminders for clinicians (system
generated alerts) to include syphilis in
routine STI testing
Optimise screening rates and
increase testing frequency
Reminders for patients (e.g. SMS text,
telephone) to get screened or rescreened
17. 2. Expanded testing in outreach venues
• Important to ensure links to healthcare services for the verification of positive screening tests,
reporting, treatment, and follow-up.
• Important to involve community organisations!
17
Source: ECDC Syphilis and congenital syphilis in Europe - A review of epidemiological trends (2007–2018) and options for response. 2019
Population Intervention Outcome
MSM (especially during outbreaks) Outreach testing
Increase syphilis detection among
individuals at risk that do not
regularly attend traditional healthcare
settings
Populations with inadequate access
to healthcare (e.g. ethnic minority
or marginalised populations)
Outreach testing
ECDC & EMCDDA guidance, 2018 - STI testing in prison settings recommended based on risk profile,
age-based and/or universal testing approaches
18. 3. Partner management services
18
Source: ECDC Syphilis and congenital syphilis in Europe - A review of epidemiological trends (2007–2018) and options for response. 2019
Population Intervention Outcome
Settings that do not usually
provide partner services (e.g.
community based clinics)
Settings with high number of
syphilis cases
Placing staff trained in partner
management
OR
improving skills of existing staff
Improve performance of partner
identification and management
Setting quality standards and indicators
(e.g. no. of partners elicited/index patients,
no. of partners tested/index patients, no. of
partners treated)
Measure performance of partner
services
Using alternative tools for notifying and
locating contacts (e.g. internet-locating
information, online tools, smartphone
applications, Facebook)
Improve performance of partner
identification and management
Detailed technical guidelines: European guidelines for management of partners of persons with STI,
IUSTI; 2014 European Guideline on the Management of Syphilis
19. Population Intervention Outcome
Populations at high risk Educational, health-promotion
and awareness-raising activities Improve knowledge of syphilis,
recognition of symptoms,
increase testing uptakeAdolescents, young adults and
MSM
Social media platforms (e.g.
Facebook, Twitter, YouTube,
Instagram and dating apps)
Healthcare providers Education to maintain a suitable
level of knowledge and
awareness
Facilitate early recognition of
symptoms and atypical
presentations
Increase syphilis testing and
case detection
4. Education, health-promotion, awareness-raising
19
Source: ECDC Syphilis and congenital syphilis in Europe - A review of epidemiological trends (2007–2018) and options for response. 2019
Important! Evaluation of education campaigns outcomes is recommended due to
mixed impact reported.
Check Yourself: A Social Marketing Campaign to Increase
Syphilis Screening in Los Angeles County 2007-2009
20. Use of social media
20
To improve knowledge on syphilis and increase access to
testing.
As alternatives to traditional patient care pathways and
partner services.
21. Biomedical interventions
More evidence is needed on the long-term consequences of this strategy for syphilis and other
infections before considering widespread implementation.
21
Population Intervention Outcome
High-risk HIV-positive MSM (with ≥ 2
syphilis episodes since HIV diagnosis)
Bolan et al. 2015 US
Daily doxycycline (100 mg) vs
contingency management, 48 weeks
Reduction in STI incidence (OR = 0.27,
95% CI 0.09-0.83, p = 0.02) at week
48 for doxycycline group. Reduction in
syphilis (2 vs 6 cases).
High risk HIV-negative MSM under PrEP
Molina et al. 2018 France
Post-exposure doxycycline (200 mg,
single dose, oral) <24 h after
condomless sex (anal or oral), 10
months
Syphilis occurrence significantly
reduced in intervention group (HR
0.27; 95% CI 0.07-0.98, p=0.047).
More GI adverse events in intervention
group (53% vs 41%, p=0.05).
22. Interventions reported by 13/28 Member States -
2019 survey
• Implementation of a national STI strategy (stand-alone strategy or
integrated in sexual health or HIV/STI strategy), will ensure
commitment of stakeholders and resources.
• Development of national syphilis action plans and enhanced
surveillance activities.
• Sexual education in schools, shifting from an HIV focus to HIV and
STI.
• Increasing number of ‘checkpoints’ for low-threshold testing in
major cities, mostly targeting MSM.
• Communication on increases in syphilis infections in epidemiological
bulletins.
22
ECDC report published on 4 Sept 2019
23. Congenital syphilis, EU/EEA, 2007–2017
23
0
5
10
15
20
25
30
0
0.5
1
1.5
2
2.5
3
3.5
2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Numberofcountries
Numberofcasesper100000livebirths
Year
Countries reporting zero cases Countries reporting cases
Congenital syphilis rate
Sources: Bulgaria, Cyprus, the Czech Republic, Denmark, Estonia, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania,
Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden and the United Kingdom
Congenital syphilis levels in the
EU/EEA have been consistently
low.
To sustain these low rates:
• effective national antenatal
screening programmes
• interventions to control
syphilis transmission among
heterosexual populations.
24. 24
“Categories of interventions have not changed much since Parran
described his approach to identifying, treating, and preventing
cases in the 1930s, but the specifics of how they are done will vary
depending on the goal, who is targeted, and opportunities.”
Peterman T. & Cha S. Context-Appropriate Interventions to Prevent Syphilis.
A Narrative Review. STD. 2018
The Battle Against Syphilis; Dr. Parran's "Shadow on
the Land" The New York Times Archives
What is new?
25. Acknowledgements
External reviewers of draft ECDC report: Raj Patel (IUSTI Europe), Magnus
Unemo (Sweden), Ian Simms (UK), Tom Peterman (USA), Melanie Taylor (WHO)
The EU/EEA STI network
ECDC colleagues: Ana-Belen Escriva, Anastasia Pharris, Caroline Daamen
Contact: Otilia.Mardh@ecdc.europa.eu; STIHIVHEP@ecdc.europa.eu
25